Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,434 | 25,837 | 25,771 | 36,931 | 34,098 |
| Receivables | 18,870 | 18,090 | 17,655 | 17,420 | 18,872 |
| Inventories | 17,211 | 15,772 | 15,777 | 18,028 | 18,259 |
| Income taxes - deferred | 1,545 | 1,546 | 1,547 | 1,556 | 1,547 |
| Other current assets | 331 | 0 | 0 | 0 | 0 |
| TOTAL | $64,391 | $61,245 | $60,750 | $73,935 | $72,776 |
| Non-Current Assets | |||||
| PPE Net | 4,128 | 4,329 | 4,375 | 4,621 | 4,365 |
| Intangibles | 55,805 | 56,341 | 56,903 | 56,948 | 56,534 |
| Other Non-Current Assets | 13,384 | 13,378 | 13,432 | 12,833 | 12,373 |
| TOTAL | $73,317 | $74,048 | $74,710 | $74,402 | $73,272 |
| Total Assets | $137,708 | $135,293 | $135,460 | $148,337 | $146,048 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,000 | 5,000 | 5,000 | 3,000 | 3,000 |
| Accounts payable and accrued liabilities | 5,060 | 4,667 | 4,682 | 4,657 | 4,877 |
| Accrued Expenses | 4,692 | 4,805 | 5,177 | 4,566 | 4,039 |
| Other current liabilities | 1,004 | 394 | 586 | 640 | 640 |
| TOTAL | $16,365 | $15,479 | $16,085 | $13,495 | $13,296 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,250 | 18,500 | 19,750 | 20,500 | 21,250 |
| Deferred Revenues | 609 | 613 | 640 | 632 | 740 |
| Other Non-Current Liabilities | 5,728 | 4,975 | 4,980 | 6,214 | 5,838 |
| TOTAL | $23,117 | $23,630 | $24,890 | $27,007 | $27,377 |
| Total Liabilities | $39,482 | $39,109 | $40,975 | $40,502 | $40,673 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,297 | 31,957 | 31,639 | 31,010 | 30,702 |
| Common Shares | 394 | 392 | 390 | 382 | 375 |
| Retained earnings | -93,298 | -94,320 | -95,039 | -78,334 | -77,352 |
| Other shareholders' equity | -2,223 | -2,086 | -2,312 | -4,034 | -6,421 |
| TOTAL | $98,226 | $96,184 | $94,485 | $107,835 | $105,375 |
| Total Liabilities And Equity | $137,708 | $135,293 | $135,460 | $148,337 | $146,048 |